37 |
Both |
Cd11b+Ly6c+ |
monocyte derived cells |
Increased |
|
|
|
CD11b+Ly6C−F480+ CD64+ CD9− |
interstitially spaced, vascular development/organization |
No difference |
|
|
|
CD11b+Ly6C−F480+ CD64+ CD9+ |
surrounding CLS, lipid metabolism |
Increased |
-Lpl, Plin2, CD63, ACp5, Ctss, Lamp2, Lipa, IL1ra, IL18, Tnf, Ccl2 |
39 |
Mouse |
Lyve lo MHCII hi |
nerve associated macs |
Unknown |
|
|
|
Lyve hi MHC II lo |
vascular associated macs |
Unknown |
|
38 |
Mouse |
“Mon1” |
|
Decreased |
-Retnla, Fn1 |
|
|
“Mon2” |
|
Decreased |
-Plac8, Clec4e |
|
|
“Mac1” |
|
Decreased |
-Retnla, Lyve1, CD209f, Cd163 -associated with perivascular macrophages from Chakarov 2019 [ref 39] |
|
|
“Mac 2” |
surrounding CLS |
Increased |
-Nche1, Cd9 |
|
|
“Mac 3” |
surrounding CLS, lipid metabolism/ phagocytosis (LAMs) |
Increased |
-Nche1, Cd9, Spp1, Trem2, Lipa, Lpl, Ctsb, Ctsl, Fabp5, Fabp5, Lgals1/3, Cd36 -associated with CD9+ from Hill 2018 [ref 37] -KO Trem2 increased weight, body fat, glucose intolerance, insulin, cholesterol, LDL |